Black, Hispanic patients with advanced liver cancer have lower chance of receiving immunotherapy

By | June 8, 2022
Racial and ethnic minorities diagnosed with advanced liver cancer have a lower chance of receiving immunotherapy, the most effective treatment for patients with the disease, according to a new study led by Cedars-Sinai Cancer investigators.